Joseph S. Zakrzewski - 17 Dec 2021 Form 4 Insider Report for Cyteir Therapeutics, Inc.

Role
Director
Signature
/s/ Andrew Gengos, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
17 Dec 2021
Net transactions value
+$1,976
Form type
4
Filing time
21 Dec 2021, 17:06:55 UTC
Previous filing
15 Dec 2021
Next filing
28 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYT Common Stock Purchase $1,976 +200 +0.25% $9.88 81,167 17 Dec 2021 Direct F1
holding CYT Common Stock 58,671 17 Dec 2021 See Footnote F2
holding CYT Common Stock 149,051 17 Dec 2021 See Footnote F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 84,523 of the shares of common stock held directly and indirectly by the Reporting Person were acquired upon early exercise of an option and are subject to forfeiture until they vest.
F2 Shares held by Z Investments, LLC, of which the Reporting Person is the Managing Director. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.
F3 Shares held by Z3 Trust, of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.